Skip to main content

Table 1 Number of studies in qualitative synthesis and meta-analysis for each burden of disease measure by AMR type

From: Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis

Burden of disease measure (outcome) Number of studies in the qualitative synthesis
(number of studies included in the meta-analysis)
Third-generation cephalosporin resistance Quinolone resistance Multidrug resistance
30-day mortality 23 (23) 9 (8) 4 (4)
All-cause mortality 51 (51) 17 (16) 5 (5)
Bacterial-attributable mortality 3 (3) 0 (0) 0 (0)
Treatment failure 15 (n/a) 7 (n/a) 2 (n/a)
Total LOS 13 (5) 4 (3) 1 (0)
Post-infection LOS 7 (2) 0 (0) 0 (0)
Hospital costs 4 (n/a) 0 (n/a) 2 (n/a)
  1. LOS, length of hospital stay; n/a, not applicable, meta-analysis not planned as per protocol; AMR, antimicrobial resistance